NCT05347342View on ClinicalTrials.gov

A Diagnostic for the Early Detection of Bladder Cancer

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

April 29, 2022

Primary Completion Date

March 27, 2026

Study Completion Date

December 30, 2026

Conditions
Bladder Cancer
Trial Locations (2)

90048

RECRUITING

Cedars-Sinai Medical Center, Los Angeles

90712

RECRUITING

Long Beach VA Healthcare System, Long Beach

Sponsors
All Listed Sponsors
collaborator

Nonagen Bioscience Corporation

INDUSTRY

collaborator

National Cancer Institute (NCI)

NIH

collaborator

VA Long Beach Healthcare System

FED

lead

Cedars-Sinai Medical Center

OTHER